Before I go much further, I want to preface this by saying that the Fisher-Wallace Stimulator uses tACS (transcranial alternating current stimulation), also known as CES (cranial electrical stimulation). This is distinct from tDCS (transcranial direct current stimulation). Fisher-Wallace would like you to believe that they're basically the same thing, since tDCS is much more well-established in the literature on the topic, but they're different.
I co-wrote a review article on tDCS for the Am J Psych residents' journal which just came out a couple of days ago:
http://ajp.psychiatryonline.org/pb/...esidents-journal/2015/October_2015.pdf#page=2
In retrospect, maybe I should have said more about tACS/CES in that article, but I didn't think to mention it because I was trying to focus on stuff that is actually shown to work.
Forgive me if I am posting in an inappropriate forum for this topic; I presume my question would be most relevant here.
We're very careful on this forum to avoid giving medical advice to patients, since we can't give you accurate advice without personally examining you. I'll give some general answers here because neuromodulation is a strong interest of mine.
I receive psychiatric care myself and I've observed others receive the same treament. Not once have I ever heard of a mental health care professional prescribing a device such as Fisher Wallace Cranial Simulator/similar devices nor discussed this with his/her patients. It is used to treat anxiety, depression, insomnia, and chronic pain such as arthritis by promoting the amount of serotonin (and other neurotransmitters) in the brain through electrical impulses.
The reason why it's not commonly prescribed is because it's not FDA approved for anything. The Fisher Wallace people try to trick you by saying it's "FDA cleared," but what that actually means is that the FDA said that they do not need to "approve" or "reject" it because they don't consider it to be a medical device.
According to this article,
www.prnewswire.com/news-releases/harvard-medical-school-researcher-publishes-favorable-study-on-fisher-wallace-cranial-stimulator-90606474.html, some "top psychiatrists" (according to the article) indicate an 80 percent success rate.
www.fisherwallace.com indicates 2,000+ prescribing doctors and 20,000+ satisfied patients which doesn't seem like a lot.
That press release you cited was written by Fisher Wallace. It has several misleading things in it. They quoted those "top psychiatrists," but when I tried to search for the source of those quotes, I didn't find any such references aside from "quotes" listed on Fisher Wallace's own website. Also, one of those two "psychiatrists" (Richard Brown) isn't actually a psychiatrist, he's a psychologist who is known for touting questionable alternative treatments. The other one (San Martin) doesn't do any research on electrical stimulation of the brain, and doesn't say anything about it in any of the information on his own website or his own publications.
Here is the a study done by Harvard on Fisher Wallace Cranial Simulator (I did not read this since it is personally very technical for me):
https://cdn.shopify.com/s/files/1/0315/7737/files/Harvard_Medical_School_Research.pdf?2806
The study is by Felipe Fregni's group. He is a leading expert on electrical/magnetic brain stimulation, and I'd believe anything that he says. But unlike what this press release would like you to believe, it is not a study on the Fisher Wallace stimulator. They would like you to believe that it is, but that statement is misleading the way they write it. They say that the study "involves" their stimulator and discusses "the brain stimulation technology used by the Fisher Wallace Cranial Stimulator," but the study doesn't specifically say much about the stimulator itself. It's mostly talking about tDCS, and doesn't say much about tACS/CES.
The press release also says that Fregni said that "The Fisher Wallace Cranial Stimulator decreases the level of neuronal activity in the motor cortex, a strong indication of why the device may be effective in some conditions with high cortical activity levels such as anxiety." But there is no such statement in the study. The only time they directly mention the Fisher Wallace stimulator, they say the following:
"Since the 1960s, a series of studies with low-intensity AC stimulation have been published (Kirsch and Smith 2004; Smith 2007), and cranial AC stimulation devices have become commercially available for personal use (e.g., Alpha-Stim, Fisher Wallace Cranial Stimulator, Transair Stimulator, etc.). However, research in this area has been inconsistent and there remains a lack of solid evidence showing the effects of weak transcranial stimulation with AC."
The world's leading expert on transcranial electrical/magnetic stimulation is probably Sarah Lisanby, who is the chair of psychiatry at Duke and previously founded the brain stimulation division at Columbia (I'm mentioning this because the press release specifically cited Columbia). Here's what she said in a recent article about the topic:
"Little consistency exists in the literature surrounding the specific parameters and electrode placements used, and there are no controlled trials on its use, making it difficult to draw conclusions about its potential value. In their meta-analysis,
Klawansky et al (1995) concluded insufficient controlled evidence existed and that available evidence was probably not adequately blinded."
And here's the source:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238088/
Why isn't this approach to treating such psychopathies more popular? Could it perhaps be the $600+ cost which Medicare/Medicaid only covers $100 for? Am I missing something?
Yes, you're missing something. I'd be much more inclined to believe Fisher Wallace if they didn't show a consistent pattern of misleading claims/statements. I am a big fan of brain stimulation, but because of companies like Fisher Wallace, doctors generally are skeptical of the types of brain stimulation that actually work.
As for tDCS - I do think that this is a useful thing. Still inexpensive, but it has a lot more science behind it than the Fisher Wallace stuff. Fisher Wallace likes to cite the tDCS research as if it supports the use of their stimulator, but there's no science to say that this is accurate.
As for FDA approval - the tDCS literature has grown quite rapidly, and the FDA is having an open meeting in about a month to discuss this in more detail with researchers/psychiatrists.
TCDCS is an interesting emerging intervention, actually with a good heft of research to back it up. Not discussed much yet.
There's uses for refractory depression, refractory psychosis, and even ADHD/improved learning (DARPA has a whole protocol on this).
I don't think Fisher Wallace CS is better than any other.
Let me reiterate that the Fisher Wallace stimulator is NOT tDCS. It is probably inferior to tDCS.